AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Total cash & short-term investments

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥81.8B
P/E ratio
48.1x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 202513,196-29.64%
Mar 31, 202418,756+41.26%
Mar 31, 202313,278-57.14%
Mar 31, 202230,977+17.96%
Mar 31, 202126,260+134.61%
Mar 31, 202011,193+31.73%
Mar 31, 20198,497+39.02%
Mar 31, 20186,112+5.20%
Mar 31, 20175,810+49.91%
Mar 31, 20163,876-20.48%
Mar 31, 20154,873

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)